Mark E. Dmytruk - Jan 2, 2024 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
Chief Financial Officer
Signature
/s/ Karen Tepichin, Attorney-in-Fact
Stock symbol
DNA
Transactions as of
Jan 2, 2024
Transactions value $
-$70,523
Form type
4
Date filed
1/5/2024, 05:09 PM
Previous filing
Dec 6, 2023
Next filing
Feb 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNA Class A Common Stock Options Exercise +65.3K +9.65% 742K Jan 2, 2024 Direct F1
transaction DNA Class A Common Stock Options Exercise +18.1K +2.44% 760K Jan 2, 2024 Direct F1
transaction DNA Class A Common Stock Options Exercise +1.64K +0.22% 762K Jan 2, 2024 Direct F2, F3
transaction DNA Class A Common Stock Sale -$70.5K -45.8K -6.01% $1.54 716K Jan 3, 2024 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNA Restricted Stock Units Options Exercise -65.3K -6.7% 909K Jan 2, 2024 Class A Common Stock 65.3K Direct F1
transaction DNA Restricted Stock Units Options Exercise -18.1K -2.56% 689K Jan 2, 2024 Class A Common Stock 18.1K Direct F1, F5
transaction DNA Class B Common Stock Options Exercise -1.64K -0.26% 634K Jan 2, 2024 Class A Common Stock 1.64K Direct F2, F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person.
F2 Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock.
F3 Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date.
F4 Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
F5 The RSUs vest in 48 equal monthly installments, which began on April 1, 2023.
F6 Includes shares of Class B Common Stock that are subject to vesting conditions.

Remarks:

Chief Financial Officer